Houlihan Lokey Advises Solmetex
Houlihan Lokey is pleased to announce that Solmetex, a portfolio company of Avista Healthcare Partners (Avista), has been acquired by AGIC Capital (AGIC).
Headquartered in Marlborough, Massachusetts, Solmetex is the largest closed-loop dental amalgam waste compliance service provider in North America and provides a variety of dental consumables and equipment to the dental market with a focus on the dental waterline, infection control, and modern dental isolation technology. The company’s NXT Hg5™ Series of Amalgam Separators and recycling program, which treat dental wastewater, are highly regarded as the best solutions for regulatory compliance. Solmetex is widely recognized as the single trusted source for comprehensive environmental solutions for its dental waste needs.
Avista is a leading New York-based private equity firm with over $8 billion invested in more than 45 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows, and robust growth prospects—targeting healthcare product and technology businesses with clear scale potential across six subsectors experiencing strong tailwinds.
AGIC is a growth-oriented private equity firm that invests in thriving middle-market businesses focused on advanced industrial and healthcare technologies in Europe and beyond. AGIC’s differentiated investment strategy combines deep business model expertise and proactive thematic research with a collaborative, management-first approach to value creation. Launched in 2015, AGIC currently has $2.2 billion in assets under management.
Houlihan Lokey served as the financial advisor to Solmetex. This transaction further strengthens and highlights the firm’s continued leadership in the medical technology industry. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2024, the group closed 25 transactions in the U.S. and was ranked by LSEG (formerly Refinitiv) as the No. 1 advisor for global M&A transactions under $1 billion.
RELATED: Healthcare, Global Medical Technology and Products, Mergers & Acquisitions